People

Directory

Contact Information

elarose@casselsbrock.com

Telephone: 416 860 5217
Fax: 416 642 7162

Cassels Brock & Blackwell LLP
2100 Scotia Plaza
40 King Street West
Toronto, ON M5H 3C2
Canada

Download vCard

Profile

Emily Larose

Emily is a partner in the firm’s Advocacy Group. She provides advice and representation to stakeholders in various regulated industries, with specific expertise working with Health Canada-regulated clients. She has experience advising on all manner of regulatory issues, risk management and policy matters and applies her regulatory expertise to product liability and class action litigation.

Among other things, Emily has worked with clients:

Providing advice on Health Canada regulatory issues, including pharmaceutical, medical device, food and natural health product marketing compliance, labeling, licensing, and mandatory problem and adverse event reporting;
Outlining the implications of legislative change in areas such as health information privacy, the Canada Consumer Product Safety Act, and the Ontario Drug Benefit Program;
Making and responding to federal and provincial access to information requests;
Advising foreign companies entering the Canadian products market on licensing and other regulatory requirements;
Advising on product liability issues, such as risk management measures, managing recalls, and defending individual and class action litigation.

Emily developed an interest in health law issues through her experiences at the Consent and Capacity Board and with the College of Nurses of Ontario. This interest has been further developed through an in-house secondment with the legal department of a multinational pharmaceutical company.

As a member of the firm’s Risk Management Committee, Emily is well versed in developing practical and proactive solutions to manage and prevent risk exposure through policy development, implementation of best practices and maximizing the use of technologies.

Emily is on the Editorial Board of Class Action Journal. She has published and spoken on a variety of topics including the reuse of single-use medical devices, national class actions, natural health product marketing, incorporation by health professionals, spoliation, cross-border discovery and access to information requests.